Current Headlines
-
FDA Approval For High Potency Fill Line
4/19/2023
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high potency vial line to manufacture a commercial product.
-
New Sterile Fill-Finish Capabilities Available In Melbourne And San Diego
4/18/2023
PCI Pharma Services (PCI), a leading global CDMO, today announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. New equipment added to these facilities will help with clinical scale and global capacity shortages
-
Wheeler Bio Announces Closing Of $31 Million Series A Round Supporting Its Clinical (CGMP) Drug Substance Manufacturing Facility In Oklahoma City
4/14/2023
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round. The round was co-led by Charles River Laboratories (NYSE:CRL) and Echo with participation from ATUM, Floating Point Advisors, Pine Ridge Ventures, Plains Venture Partners (a subsidiary of i2E), Seagull Capital, and Alloy Therapeutics.
-
Lubrizol’s Apisolex Technology Voted Grand Winner Of The 7th Annual Medicine Maker Innovation Awards
4/6/2023
Lubrizol Life Science (LLS) - Health, a leading pharmaceutical company, has won The Medicine Maker 2022 Innovation Award for its groundbreaking technology – Apisolex Polymer solubilizing excipient.
-
Life Sciences Manufacturing Leader, Meissner, To Build New Manufacturing Facility In Athens, Georgia
4/5/2023
Governor Brian P. Kemp announced that Meissner Corporation, an industry leader in advanced microfiltration and therapeutic manufacturing systems for the development and manufacture of pharmaceutical drugs, therapeutics, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens-Clarke County. The project will create more than 1,700 new jobs over the next eight years.
-
New Facilities Offer Early Phase cGMP Production With Cell & Gene Focus
3/30/2023
The rapidly growing interest in cell and gene therapies entails a new approach to manufacturing. JIB's expansion will empower pilot-scale production of early phase clinical therapy material for clients.
-
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
3/24/2023
Agilis is a trusted human factors partner for the global medical market. They specialize in helping new and established companies achieve successful HF submissions while navigating the complex global regulatory landscape, resulting in safe and effective medical products being brought to market.
- Stevanato Group Collaborates With Thermo Fisher Scientific To Bring Its Innovative On-Body Delivery System Platform To Market 3/23/2023
-
Qosina Releases New 2023 Product Catalog
3/22/2023
Qosina, a global supplier of OEM single-use components to the medical and bioprocess industries, is thrilled to announce the release of its latest full-line product catalog, available in both print and digital formats.
- ThermoGenesis Announces New ReadyStart cGMP Suites For Early-Stage Cell And Gene Therapy Companies In California 3/21/2023